The correlation of interstitial change with renal prognosis in patients with myeloperoxidase-ANCA-associated glomerulonephritis: a single-center retrospective analysis

被引:0
作者
Kong, Weiwei [1 ,2 ,3 ,4 ]
Wang, Jiahui [1 ,2 ,3 ,4 ]
Wang, Meifang [1 ,2 ,3 ,4 ]
Ni, Anqi [1 ,2 ,3 ,4 ]
Huang, Xiaohan [1 ,2 ,3 ,4 ]
Chen, Liangliang [1 ,2 ,3 ,4 ]
Zhou, Qin [1 ,2 ,3 ,4 ]
Wang, Huiping [1 ,2 ,3 ,4 ]
Chen, Jianghua [1 ,2 ,3 ,4 ]
Han, Fei [1 ,2 ,3 ,4 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Kidney Dis Ctr, Sch Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Inst Nephrol, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China
[3] Key Lab Kidney Dis Prevent & Control Technol, Zhejiang Prov, 79 Qingchun Rd, Zhejiang 310003, 310003, Hangzhou, Chin, Myanmar
[4] Zhejiang Clin Res Ctr Kidney & Urinary Syst Dis, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China
关键词
Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis; Interstitial fibrosis/tubular atrophy; Interstitial inflammation; Renal survival; CLINICAL PREDICTORS; VASCULITIS; DETERMINANTS; SURVIVAL; OUTCOMES; BIOPSY;
D O I
10.1007/s10067-023-06753-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objects We aim to explore the correlation between active/chronic tubulointerstitial injury and renal survival, and to compare their predictive value in patients with myeloperoxidase (MPO)-anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (AAGN). Method A total of 225 patients with MPO-AAGN diagnosed between February 2004 and December 2020 were included. Survival and univariate/multivariate Cox regression analyses were used to analyze the prognostic value of interstitial inflammation and interstitial fibrosis/tubular atrophy (IF/TA). Results Of the 225 patients, 73 (32.4%) patients developed end-stage renal disease (ESRD) requiring maintenance dialysis. Interstitial inflammation>50% and IF/TA>50% were important predictors for ESRD in MPO-AAGN in multivariate Cox regression analysis adjusted by age, gender, estimated glomerular filtration rate (eGFR) <= 15 ml/min/1.73m(2), and normal glomeruli% (classified by <25%, 25-50%, >50%). Furthermore, we conducted stratified Cox regression analysis and found different results in the subgroups of eGFR>15 ml/min/1.73m(2) and eGFR <= 15 ml/min/1.73m(2). Interstitial inflammation>50% and IF/TA>50% were significant risk factors for ESRD in the subgroup of eGFR>15 ml/min/1.73m(2), but not or less significant in the subgroup of eGFR <= 15 ml/min/1.73m(2). Similarly, the survival analysis according to interstitial inflammation>50%/<= 50% and IF/TA>50%/<= 50% showed significant differences in the subgroup of eGFR>15 ml/min/1.73m(2), but not or less significant in the subgroup of eGFR <= 15 ml/min/1.73m(2). Conclusions Interstitial inflammation>50% and IF/TA>50% were prognostic factors for renal survival in MPO-AAGN. In particular, interstitial inflammation and IF/TA had a better predictive ability in the subgroup of eGFR>15 ml/min/1.73m(2). Key Points center dot Interstitial inflammation>50% and IF/TA>50% can help to predict renal survival in MPO-AAGN. center dot Both interstitial inflammation and IF/TA had a better predictive ability in the subgroup of eGFR>15 ml/min/1.73m(2) than those in the subgroup of eGFR <= 15 ml/min/1.73m(2).
引用
收藏
页码:377 / 386
页数:10
相关论文
共 39 条
[21]   Repeat protocol renal biopsy in ANCA-associated renal vasculitis [J].
Hruskova, Zdenka ;
Honsova, Eva ;
Berden, Annelies E. ;
Rychlik, Ivan ;
Lanska, Vera ;
Zabka, Jiri ;
Bajema, Ingeborg M. ;
Tesar, Vladimir .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (09) :1728-1732
[22]   2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides [J].
Jennette, J. C. ;
Falk, R. J. ;
Bacon, P. A. ;
Basu, N. ;
Cid, M. C. ;
Ferrario, F. ;
Flores-Suarez, L. F. ;
Gross, W. L. ;
Guillevin, L. ;
Hagen, E. C. ;
Hoffman, G. S. ;
Jayne, D. R. ;
Kallenberg, C. G. M. ;
Lamprecht, P. ;
Langford, C. A. ;
Luqmani, R. A. ;
Mahr, A. D. ;
Matteson, E. L. ;
Merkel, P. A. ;
Ozen, S. ;
Pusey, C. D. ;
Rasmussen, N. ;
Rees, A. J. ;
Scott, D. G. I. ;
Specks, U. ;
Stone, J. H. ;
Takahashi, K. ;
Watts, R. A. .
ARTHRITIS AND RHEUMATISM, 2013, 65 (01) :1-11
[23]  
Kong W, 2023, CLIN EXP RHEUMATOL, V41, P893, DOI 10.55563/clinexprheumatol/ozkrr0
[24]   The clinical course of ANCA small-vessel vasculitis on chronic dialysis [J].
Lionaki, Sofia ;
Hogan, Susan L. ;
Jennette, Caroline E. ;
Hu, Yichun ;
Hamra, Julie B. ;
Jennette, J. Charles ;
Falk, Ronald J. ;
Nachman, Patrick H. .
KIDNEY INTERNATIONAL, 2009, 76 (06) :644-651
[25]   Cellular and molecular mechanisms of renal fibrosis [J].
Liu, Youhua .
NATURE REVIEWS NEPHROLOGY, 2011, 7 (12) :684-696
[26]   Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis [J].
Menez, Steven ;
Hruskova, Zdenka ;
Scott, Jennifer ;
Cormican, Sarah ;
Chen, Min ;
Salama, Alan D. ;
Alasfar, Sami ;
Little, Mark A. ;
Safrankova, Hana ;
Honsova, Eva ;
Tesar, Vladimir ;
Geetha, Duvuru .
AMERICAN JOURNAL OF NEPHROLOGY, 2018, 48 (06) :465-471
[27]   End-stage renal disease in ANCA-associated vasculitis [J].
Moiseev, Sergey ;
Novikov, Pavel ;
Jayne, David ;
Mukhin, Nikolay .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (02) :248-253
[28]   Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis [J].
Neumann, I ;
Kain, R ;
Regele, H ;
Soleiman, A ;
Kandutsch, S ;
Meisl, FT .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (01) :96-104
[29]   Validation of the Antineutrophil Cytoplasmic Antibody Renal sk Score and Modification of the Score in a Chinese Cohort Ri With a Majority of Myeloperoxidase-Positive Patients [J].
Ni, Anqi ;
Chen, Liangliang ;
Lan, Lan ;
Wang, Yaomin ;
Ren, Pingping ;
Zhu, Yilin ;
Xu, Ying ;
Shen, Xiaoqi ;
Zhou, Qin ;
Huang, Xiaohan ;
Wang, Huiping ;
Chen, Jianghua ;
Han, Fei .
JOURNAL OF RHEUMATOLOGY, 2023, 50 (05) :662-670
[30]   The ESRD Quality Incentive Program: Everything Can Be Improved [J].
Reaves, Allison C. ;
Weiner, Daniel E. ;
Schwartz, William B. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (06) :907-910